NEW YORK, Oct. 03, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against DexCom, Inc. (NASDAQ: DXCM) and certain of the ...

We expect the upcoming G7 CGM will build on those strengths. We continue to think Dexcom's strength in innovation puts the company on firm footing. First, the precision of its CGM remains ...

Dexcom G7, a continuous glucose monitoring system that allows people with diabetes to track their blood sugar levels in real time, announced Wednesday it's integrating directly with Apple Watch ...

DexCom Inc. DXCM recently announced that its G7 Continuous Glucose Monitoring (CGM) System will be added to the Régie de l'assurance maladie du Québec (RAMQ) Public Prescription Drug Insurance Plan.

Business Wire • 4 months ago Dexcom G7 Now Connects Directly to Apple Watch in the U.S. SAN DIEGO, June 05, 2024--DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose ...

Since 2019, DexCom has launched new products like the DexCom One and the G7; it's also expanded into new territories, including its grand entrance into Latin America via Argentina in 2023.

Whether you’re traveling with one pair of sunglasses or your full collection, these sturdy cases will protect your precious lenses. Theresa Holland is a freelance commerce writer and editor ...

the G7, rapidly overtakes its prior generation products and becomes a majority of company revenues.” In another article, we discussed DexCom, Inc. (NASDAQ:DXCM) and shared Baron Asset Fund’s ...

DexCom ( NASDAQ:DXCM ) Third Quarter 2024 Results Key Financial Results Revenue: US$994.2m (up 2.0% from 3Q 2023). Net... Dexcom stock closed in the red on Friday after the diabetes devices player ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...